Table 3.

Number of individuals with synkinesis at House-Brackmann 2.0 (FNGS 2.0) and SB synkinesis subscore along with Chi-square analysis for individuals with and without synkinesis between the groups.

	MEPP group				Control group				Chi-square analysis
Assessment timepoints	Baseline (Flaccid phase)	1-2-3 MPO (Paretic phase)	4-5-6 MPO (Synkinetic phase)	1 YPO (Chronic phase)	Baseline (Flaccid phase)	1-2-3 MPO (Paretic phase)	4-5-6 MPO (Synkinetic phase)	1 YPO (Chronic phase)
Number of individuals with synkinesis at FNGS 2.0 ‘s synkinesis subscore	0	1	3	5	0	5	8	13	X2 = 7.117 P = 0.008*
Number of individuals with synkinesis at SB ‘s synkinesis subscore	0	2	4	5	0	4	9	12	X2 = 3.772 P ≤ 0.05*

Note. FNGS 2.0: Facial Nerve Grading Scale 2.0 or House-Brackmann 2.0; SB: Sunnybrook; SD: standard deviation; MPO: months post-onset; YPO: year post-onset

*Significant differences between the groups at the Chi-Square analysis (alpha = 0.05).